Journal Of Clinical Oncology (jco) Podcast
Minimal Residual Disease (MRD) in Acute Myeloid Leukemia- Are we Ready for Individualized Risk Assessment Based on MRD?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:09:21
- More information
Informações:
Synopsis
Before we can use MRD as a guide of post-remission therapy in AML, we have to standardize our methods for MRD quantification and agree on the definition of MRD-positive versus MRD-negative patients.
